曲美他嗪治疗冠心病、心绞痛疗效观察
摘要
曲美他嗪(TMZ),商品名为万爽力(由法国施维雅药厂生产),是近年来逐渐引起人们重视,并已开始应用临床的抗心绞痛新药.本文选择确诊为冠心病稳定劳力性心绞痛病人40例,观察加有TMZ治病前后临床疗效及病人运动耐量.
出处
《黑龙江医药》
CAS
2005年第5期380-381,共2页
Heilongjiang Medicine journal
参考文献6
-
1方全.治疗心肌缺血的"3-KAT"抑制剂[N].中国医学论坛报,2001,27(6):9.
-
2Stanley WC, Lopaschuk GD, Hall JL.Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for Pharmacological intenventions[J]. Cardiovasc Res, 1997,33(2):243-257
-
3Fantini E, Demaison L, Sentex E, et al. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation[J]. J Mol Cell Cardiol. 1994,26:949-958
-
4Guarnieri C, Finelli C, Zini M, et al. Effects of trimetazidine on the calcium transport and oxidative phosphyorylation of isolated rat herat mitochondrial function. Basic Res Cardiol. 1997Apr; 92:90-95
-
5Maupoil V, Rochette L, Tabard A, et al. Evaluation of free radical formation during low-flow ischemia and reperfusion isolated rat hertr[J]. Cardiovas Drugs Ther. 1990,4(suppl 4):791-795
-
6Devynck MA, Joulin Y, Mazead M, et al. Acute membrance effects of trimetazidine in human platelets[J].Eur J Pharmacol, 1993,245(2):105-110
